DXCM— DEXCOM INC

Health Care$33.4B mkt cap

Metric	FY2025	FY2024	FY2023	FY2022
Revenue	$4.66B+15.6%	$4.03B+11.3%	$3.62B+24.5%	$2.91B
Cost of sales	$1.86B+16.6%	$1.59B+19.6%	$1.33B+29.9%	$1.03B
Gross profit	$2.80B+14.9%	$2.44B+6.5%	$2.29B+21.5%	$1.88B
Research and development	$599.1M+8.5%	$552.4M+9.2%	$505.8M+4.5%	$484.2M
Selling, general and administrative	$1.29B+0.4%	$1.29B+8.5%	$1.19B+17.6%	$1.01B
Total operating expenses	$1.89B+2.8%	$1.84B+8.7%	$1.69B+13.4%	$1.49B
Operating income	$911.8M+52.0%	$600.0M+0.4%	$597.7M+52.8%	$391.2M
Other income, net	$176.6M+62.0%	$109.0M-3.3%	$112.7M+28275.0%	-$400K
Income before income taxes	$1.09B+53.5%	$709.0M-0.2%	$710.4M+81.8%	$390.8M
Income tax expense	$252.1M+89.8%	$132.8M-21.4%	$168.9M+240.5%	$49.6M
Net income	$836.3M+45.1%	$576.2M+6.4%	$541.5M+58.7%	$341.2M
Basic net income per share (in usd per share)	$2140000.00+46.6%	$1460000.00+4.3%	$1400000.00+59.1%	$880000.00
Shares used to compute basic net income per share (in shares)	$390200000.00-0.9%	$393600000.00+2.0%	$386000000.00-0.9%	$389400000.00
Diluted net income per share (in usd per share)	$2090000.00+47.2%	$1420000.00+9.2%	$1300000.00+58.5%	$820000.00
Shares used to compute diluted net income per share (in shares)	$405500000.00-1.7%	$412700000.00-3.0%	$425500000.00-0.5%	$427500000.00

Source: SEC EDGAR XBRL. % change vs prior period shown where available.

Pro feature

Unlock 12 more years of annual history and full quarterly detail on Pro.

Source: SEC EDGAR 10-K and 10-Q filings. Last 4 years annual and quarterly free, full history (up to 20 years) on Pro.